Arthritis Care Res (Hoboken). 2012 May;64(5):625-39. doi: 10.1002/acr.21641.

2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis.

Source

University of Alabama at Birmingham.510 20th Street South, Birmingham, AL 35294, USA. Jasvinder.md@gmail.com

Comment in

American College of Rheumatology treatment guidelines continue to omit guidance on glucocorticoids: comment on the article by Singh et al. [Arthritis Care Res (Hoboken). 2012]
American College of Rheumatology treatment guidelines continue to omit guidance on glucocorticoids: comment on the article by Singh et al.Boers M, Kirwan JR, Bijlsma JW. Arthritis Care Res (Hoboken). 2012 Oct; 64(10):1622.
Oral glucocorticoids should be included in any recommendation for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in the treatment of rheumatoid arthritis: comment on the article by Singh et al. [Arthritis Care Res (Hoboken). 2012]
Oral glucocorticoids should be included in any recommendation for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in the treatment of rheumatoid arthritis: comment on the article by Singh et al.Conn DL. Arthritis Care Res (Hoboken). 2012 Oct; 64(10):1622-3; author reply 1623-4.
Updated recommendations for the treatment of rheumatoid arthritis: another step on a long road. [Arthritis Care Res (Hoboken). 2012]
Updated recommendations for the treatment of rheumatoid arthritis: another step on a long road.Daikh DI, St Clair EW. Arthritis Care Res (Hoboken). 2012 May; 64(5):648-51.
Level of the indication of biologic agents in the 2012 American College of Rheumatology recommendations for the treatment of rheumatoid arthritis: comment on the article by Singh et al. [Arthritis Care Res (Hoboken). 2013]
Level of the indication of biologic agents in the 2012 American College of Rheumatology recommendations for the treatment of rheumatoid arthritis: comment on the article by Singh et al.Graudal N, Jürgens G. Arthritis Care Res (Hoboken). 2013 May; 65(5):832.
Reply. [Arthritis Care Res (Hoboken). 2013]
Reply.Singh JA, Saag KG, Furst D. Arthritis Care Res (Hoboken). 2013 May; 65(5):832-3.

PMID:: 22473917; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances, Grant Support

Publication Types

Review

MeSH Terms

Substances

Grant Support

K23 AR053351/AR/NIAMS NIH HHS/United States

LinkOut - more resources

Full Text Sources

Medical

Supplemental Content

Save items

Related citations in PubMed

Oral glucocorticoids should be included in any recommendation for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in the treatment of rheumatoid arthritis: comment on the article by Singh et al. [Arthritis Care Res (Hoboken). ...]
Oral glucocorticoids should be included in any recommendation for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in the treatment of rheumatoid arthritis: comment on the article by Singh et al.
Conn DL. Arthritis Care Res (Hoboken). 2012 Oct; 64(10):1622-3; author reply 1623-4.
American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis. [Arthritis Rheum. 2008]
American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis.
Saag KG, Teng GG, Patkar NM, Anuntiyo J, Finney C, Curtis JR, Paulus HE, Mudano A, Pisu M, Elkins-Melton M, et al. Arthritis Rheum. 2008 Jun 15; 59(6):762-84.
The 2008 American College of Rheumatology recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis: where the rubber meets the road. [Arthritis Rheum. 2008]
The 2008 American College of Rheumatology recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis: where the rubber meets the road.
Bathon JM, Cohen SB. Arthritis Rheum. 2008 Jun 15; 59(6):757-9.
Review Recommendations for the use of biologic therapy in rheumatoid arthritis: update from the Italian Society for Rheumatology I. Efficacy. [Clin Exp Rheumatol. 2011]
Review Recommendations for the use of biologic therapy in rheumatoid arthritis: update from the Italian Society for Rheumatology I. Efficacy.
Caporali R, Conti F, Alivernini S, Atzeni F, Seriolo B, Cutolo M, Valesini G, Ferraccioli G, Sarzi-Puttini P, Salvarani C, et al. Clin Exp Rheumatol. 2011 May-Jun; 29(3 Suppl 66):S7-14. Epub 2011 Jul 26.
Review Recommendations for the use of biologic therapy in rheumatoid arthritis: update from the Italian Society for Rheumatology II. Safety. [Clin Exp Rheumatol. 2011]
Review Recommendations for the use of biologic therapy in rheumatoid arthritis: update from the Italian Society for Rheumatology II. Safety.
Favalli EG, Caporali R, Sinigaglia L, Pipitone N, Miniati I, Montecucco C, Matucci-Cerinic M, Italian Society for Rheumatology. Clin Exp Rheumatol. 2011 May-Jun; 29(3 Suppl 66):S15-27. Epub 2011 Aug 29.

See reviews... See all...

Cited by 16 PubMed Central articles

Tumor necrosis factor-blocker dose escalation in rheumatoid arthritis patients in a pharmacy benefit management setting. [Adv Ther. 2013]
Tumor necrosis factor-blocker dose escalation in rheumatoid arthritis patients in a pharmacy benefit management setting.
Blume SW, Fox KM, Joseph G, Chuang CC, Thomas J, Gandra SR. Adv Ther. 2013 May; 30(5):517-27. Epub 2013 Jun 6.
Impact of rheumatoid arthritis disease activity test on clinical practice. [PLoS One. 2013]
Impact of rheumatoid arthritis disease activity test on clinical practice.
Peabody JW, Strand V, Shimkhada R, Lee R, Chernoff D. PLoS One. 2013; 8(5):e63215. Epub 2013 May 7.
Comorbidity profile among patients with rheumatoid arthritis and the impact on prescriptions trend. [Clin Med Insights Arthritis Mu...]
Comorbidity profile among patients with rheumatoid arthritis and the impact on prescriptions trend.
Al-Bishri J, Attar S, Bassuni N, Al-Nofaiey Y, Qutbuddeen H, Al-Harthi S, Subahi S. Clin Med Insights Arthritis Musculoskelet Disord. 2013; 6:11-8. Epub 2013 Apr 4.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

2012 update of the 2008 American College of Rheumatology recommendations for the...
2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis.
Arthritis Care Res (Hoboken). 2012 May ;64(5):625-39. doi: 10.1002/acr.21641.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: